Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Juana, Hernandez"'
Autor:
Juana Hernandez, Sharyam Caicedo
Publikováno v:
Neumología Pediátrica. 17:148-152
Las malformaciones pulmonares congénitas (MPC) conforman un grupo de entidades originadas por alteraciones en la embriogénesis del pulmón y de las vías respiratorias que se producen de acuerdo al nivel del árbol traqueobronquial donde se dé el
Publikováno v:
LATAM Revista Latinoamericana de Ciencias Sociales y Humanidades. 4
Define the characteristics of the supply companies linked to an automotive company, inquire about the position of the value chain, and supplier development. Information was collected from 30 companies directly linked to the company's production proce
Autor:
Mónica Casalet Ravenna, Federico Stezano, Fernando Quezada, Sergio Carrera Riva Palacio, Edgar Buenrostro Mercado, Florencia Barletta, Mariano Pereira, Sergio Rodríguez, Gabriel Yoguel, Juana Hernández Chavarria, Jorge Carrillo, Ismael Plascencia, Christian Lévesque, Blandine Émilien, Lucie Morissette, Laurence Solar-Pelletier, Prudenzio Mochi Alemán, Cristina Girardo, Nydia Lara Zavala
En este libro se analiza un nuevo paradigma del conocimiento basado en la creciente interacción entre diferentes disciplinas y tecnologías. Esta transformación surge con el desarrollo de la biotecnología, la nanotecnología, las tecnologías de l
Autor:
Karina Ansolabehere, Fernando Cortés, Liliana Martínez Pérez, Gisela Zaremberg, Francisco J. Cantamutto, Agostina Costantino, Jairo Antonio López Pacheco, Isaac Cisneros, Juana Hernández Chavarría, Carolina Escobar Neira
Además de ofrecernos un resumen de los alcances de la noción de diseño de investigación, junto con su historia y las diversas maneras en que ha sido clasificado, lo innovador y distinto de este libro es que son los propios científicos sociales e
Autor:
Juana Hernandez Gomez, Juan Gabriel Gonzalez Serna, Azucena Montes Rendón, Nimrod González Franco, Felix Ortiz Carreon, Ana Maria Pena Jimenez
Publikováno v:
IEEE Latin America Transactions. 14:563-568
Commonly, humans have the ability to express their emotions clearly and accurately through oral or written communication. However, a considerable part of the population is limited to express their emotions because they have little mobility in their b
Autor:
Juan-Manuel Sancho, Andreas Viardot, Corinne Haioun, Thomas Perretti, Juana Hernandez, Matthew J. Matasar, Andrew McMillan
Publikováno v:
Journal of Clinical Oncology. 38:TPS8070-TPS8070
TPS8070 Background: The antibody-drug conjugate polatuzumab vedotin (pola; POLIVY) targets CD79b on B-cell malignancies. Pola plus bendamustine and rituximab (BR) has significantly improved efficacy vs BR alone in patients (pts) with R/R DLBCL. As a
Autor:
Juana Hernandez, Andreas Viardot, Andrew McMillan, Thomas Perretti, Matthew J. Matasar, Juan-Manuel Sancho, Corinne Haioun
Publikováno v:
Blood. 134:5317-5317
Introduction: The antibody-drug conjugate polatuzumab vedotin (pola) targets CD79b on B-cell malignancies. Pola in combination with bendamustine and rituximab (BR) improved complete response (CR) rate and overall survival (OS) in patients with relaps
Publikováno v:
British Journal of Haematology
British Journal of Haematology, Wiley, 2018, 180 (2), pp.217-223. ⟨10.1111/bjh.15023⟩
British Journal of Haematology, 2018, 180 (2), pp.217-223. ⟨10.1111/bjh.15023⟩
British Journal of Haematology, Wiley, 2018, 180 (2), pp.217-223. ⟨10.1111/bjh.15023⟩
British Journal of Haematology, 2018, 180 (2), pp.217-223. ⟨10.1111/bjh.15023⟩
Given that there are currently no clear recommendations regarding therapeutic options for rituximab refractory/relapsed follicular lymphoma patients, this study aimed to describe the real-life management of patients with refractory follicular lymphom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82fe1b5230746e75fea372f61bc851fd
https://hal-normandie-univ.archives-ouvertes.fr/hal-02194318
https://hal-normandie-univ.archives-ouvertes.fr/hal-02194318
Autor:
Henri Roché, Jean Marc Ferrero, Jean-Yves Pierga, Joseph Gligorov, Christelle Levy, Mario Campone, Juana Hernandez, Jacques Bonneterre, Thomas Bachelot, Patrice Viens, Emmanuelle Charafe-Jauffret, Thierry Petit, François-Clément Bidard, Florence Lerebours
Publikováno v:
Clinical Cancer Research. 21:1298-1304
Purpose: The BEVERLY-2 single-arm phase II trial assessed the efficacy and safety of combining neoadjuvant chemotherapy with bevacizumab and trastuzumab for the treatment of HER2-positive inflammatory breast cancer (IBC). Here, we report the results
Autor:
Marc Espié, Alain Lortholary, Katelle Joly, D. Serin, Xavier Pivot, Juana Hernandez, Florence Dalenc, Corinne Veyret, Jean-Yves Pierga, Joseph Gligorov, Anne-Claire Hardy-Bessard, Remy Delva
Publikováno v:
Bulletin du Cancer. 101:780-788
Resume L’etude internationale de phase IIIb, ATHENA a evalue l’association bevacizumab-chimiotherapie de premiere ligne a base de taxanes, en pratique clinique dans le cancer du sein metastatique (CSm) HER2-negatif. Chez les 365patientes (ptes) i